Inventor · disambiguated record
Antonio Garrido Montalban
Also filed as: MONTALBAN ANTONIO G · MONTALBAN ANTONIO GARRIDO
23 granted patents·5 pending applications·163 citations·filing 2004–2025
96Inventor score
Files withARENA PHARM INC20ITHERX PHARMACEUTICALS INC4BLACKBURN ANTHONY C1KEMIA INC1MONTALBAN ANTONIO GARRIDO1
Top patents by PatentIndex Score
28 records- 0197US11091435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2020·Granted Aug 17, 2021·11 cites·15 claims
- 0297US10676435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2019·Granted Jun 9, 2020·12 cites·25 claims
- 0396US11884626B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2021·Granted Jan 30, 2024·3 cites·16 claims
- 0496US11771695B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Oct 3, 2023·4 cites·11 claims
- 0595US11149292B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2016·Granted Oct 19, 2021·8 cites·21 claims
- 0694US11560369B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Jan 24, 2023·2 cites·20 claims
- 0793US10981895B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2018·Granted Apr 20, 2021·4 cites·16 claims
- 0893US10301262B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2016·Granted May 28, 2019·11 cites·50 claims
- 0993US10183930B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 22, 2019·10 cites·11 claims
- 1093US9458136B2Crystalline forms and processes for the preparation of cannabinoid receptor modulatorsBLACKBURN ANTHONY C·Filed 2012·Granted Oct 4, 2016·11 cites·34 claims
- 1193US9447041B2Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2015·Granted Sep 20, 2016·12 cites·22 claims
- 1292US10632134B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Granted Apr 28, 2020·5 cites·16 claims
- 1392US9175320B2Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2014·Granted Nov 3, 2015·15 cites·42 claims
- 1491US9867822B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 16, 2018·7 cites·18 claims
- 1591US9492447B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2015·Granted Nov 15, 2016·9 cites·20 claims
- 1690US12378198B2Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2023·Granted Aug 5, 2025·0 cites·40 claims
- 1789US2025346560A1Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disordersARENA PHARM INC·Filed 2025·Application pending·0 cites
- 1888US9597340B2Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Granted Mar 21, 2017·9 cites·17 claims
- 1988US8853419B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereofMONTALBAN ANTONIO GARRIDO·Filed 2011·Granted Oct 7, 2014·17 cites·24 claims
- 2082US7919617B2Cytokine inhibitorsITHERX PHARMACEUTICALS INC·Filed 2009·Granted Apr 5, 2011·4 cites·3 claims
- 2182US7897599B2Cytokine inhibitorsITHERX PHARMACEUTICALS INC·Filed 2009·Granted Mar 1, 2011·4 cites·3 claims
- 2276US11674163B2Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereofARENA PHARM INC·Filed 2021·Granted Jun 13, 2023·0 cites·15 claims
- 2371US7749999B2Alpha-ketoamides and derivatives thereofITHERX PHARMACEUTICALS INC·Filed 2004·Granted Jul 6, 2010·5 cites·35 claims
- 2467US2020069681A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Application pending·0 cites
- 2564US12109219B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2020·Granted Oct 8, 2024·0 cites·20 claims
- 2663US2018280386A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Application pending·0 cites
- 2750US2010273797A1Alpha-ketoamides and derivatives thereofITHERX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2839US2004248850A1Compounds for the treatment of HIV infectionKEMIA INC·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antonio Garrido Montalban files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →